DK3556869T3 - Sammensætninger og fremgangsmåder til sekventering af polynukleotider - Google Patents

Sammensætninger og fremgangsmåder til sekventering af polynukleotider Download PDF

Info

Publication number
DK3556869T3
DK3556869T3 DK19161148.2T DK19161148T DK3556869T3 DK 3556869 T3 DK3556869 T3 DK 3556869T3 DK 19161148 T DK19161148 T DK 19161148T DK 3556869 T3 DK3556869 T3 DK 3556869T3
Authority
DK
Denmark
Prior art keywords
polynucleotides
compositions
sequence
methods
Prior art date
Application number
DK19161148.2T
Other languages
Danish (da)
English (en)
Inventor
Eric Stava
Jens H Gundlach
Jeffrey G Mandell
Kevin L Gunderson
Ian M Derrington
Hosein Himani
Original Assignee
Illumina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc filed Critical Illumina Inc
Application granted granted Critical
Publication of DK3556869T3 publication Critical patent/DK3556869T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Food Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK19161148.2T 2013-11-26 2014-11-26 Sammensætninger og fremgangsmåder til sekventering af polynukleotider DK3556869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361909316P 2013-11-26 2013-11-26
EP14830903.2A EP3074534B1 (en) 2013-11-26 2014-11-26 Methods for polynucleotide sequencing

Publications (1)

Publication Number Publication Date
DK3556869T3 true DK3556869T3 (da) 2023-10-02

Family

ID=52424089

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19161148.2T DK3556869T3 (da) 2013-11-26 2014-11-26 Sammensætninger og fremgangsmåder til sekventering af polynukleotider
DK14830903.2T DK3074534T3 (da) 2013-11-26 2014-11-26 Fremgangsmåder til polynukleotidsekventering

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14830903.2T DK3074534T3 (da) 2013-11-26 2014-11-26 Fremgangsmåder til polynukleotidsekventering

Country Status (12)

Country Link
US (5) US9689033B2 (enExample)
EP (3) EP3074534B1 (enExample)
JP (4) JP6800749B2 (enExample)
CN (2) CN105934522B (enExample)
AU (3) AU2014354726B2 (enExample)
CA (2) CA3157586C (enExample)
DK (2) DK3556869T3 (enExample)
ES (2) ES2735015T3 (enExample)
FI (1) FI3556869T3 (enExample)
LT (1) LT3074534T (enExample)
SI (1) SI3074534T1 (enExample)
WO (2) WO2015081211A2 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
EP3663412B1 (en) * 2011-09-23 2022-03-09 Oxford Nanopore Technologies PLC Analysis of a polymer comprising polymer units by means of translocation through a nanopore
EP3736339B1 (en) 2012-02-16 2022-07-27 Oxford Nanopore Technologies plc Analysis of measurements of a polymer
WO2013153359A1 (en) 2012-04-10 2013-10-17 Oxford Nanopore Technologies Limited Mutant lysenin pores
GB201222928D0 (en) 2012-12-19 2013-01-30 Oxford Nanopore Tech Ltd Analysis of a polynucleotide
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
ES2735015T3 (es) * 2013-11-26 2019-12-13 Illumina Inc Composiciones y métodos para secuenciar polinucleótidos
EP3097210B2 (en) 2014-01-22 2022-04-20 Oxford Nanopore Technologies Limited Method for attaching one or more polynucleotide binding proteins to a target polynucleotide
US10359395B2 (en) 2014-02-19 2019-07-23 University Of Washington Nanopore-based analysis of protein characteristics
US10443097B2 (en) 2014-05-02 2019-10-15 Oxford Nanopore Technologies Ltd. Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
CN119899249A (zh) 2014-09-01 2025-04-29 弗拉芒区生物技术研究所 突变csgg孔
EP3971300B1 (en) 2014-10-16 2024-06-05 Oxford Nanopore Technologies plc Sorting of polymers
GB201502810D0 (en) 2015-02-19 2015-04-08 Oxford Nanopore Tech Ltd Method
WO2017027518A1 (en) * 2015-08-10 2017-02-16 Stratos Genomics, Inc. Single molecule nucleic acid sequencing with molecular sensor complexes
CA3002886A1 (en) * 2015-10-21 2017-04-27 F. Hoffmann-La Roche Ag Use of fluoropolymers as a hydrophobic layer to support lipid bilayer formation for nanopore based dna sequencing
KR102222191B1 (ko) 2016-03-02 2021-03-02 옥스포드 나노포어 테크놀로지즈 리미티드 돌연변이체 기공
CN118272512A (zh) 2016-04-06 2024-07-02 牛津纳米孔科技公开有限公司 突变体孔
WO2017180141A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
US10317392B2 (en) * 2016-06-23 2019-06-11 Roche Sequencing Solutions, Inc. Formation and calibration of nanopore sequencing cells
US10648027B2 (en) 2016-08-08 2020-05-12 Roche Sequencing Solutions, Inc. Basecalling for stochastic sequencing processes
PL3529380T3 (pl) 2016-10-19 2022-10-24 Illumina, Inc. Sposoby chemicznej ligacji kwasów nukleinowych
GB201707122D0 (en) 2017-05-04 2017-06-21 Oxford Nanopore Tech Ltd Pore
EP3645552B1 (en) 2017-06-30 2023-06-28 Vib Vzw Novel protein pores
EP3682020B1 (en) * 2017-09-15 2025-09-03 Illumina, Inc. Sequence-detection system
WO2019055856A1 (en) * 2017-09-15 2019-03-21 Illumina, Inc. ACCORDING AND CALIBRATION CHARACTERISTICS OF A SEQUENCE DETECTION SYSTEM
US10310959B2 (en) 2017-11-07 2019-06-04 Bank Of America Corporation Pre-deployment validation system using intelligent databases
WO2019243421A1 (en) * 2018-06-21 2019-12-26 F. Hoffmann-La Roche Ag Tunneling junctions for sequencing
EP3814529A1 (en) * 2018-06-26 2021-05-05 Electronic Biosciences Inc. Controlled nanopore translocation utilizing extremophilic replication proteins
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
JP2020031557A (ja) * 2018-08-28 2020-03-05 株式会社日立ハイテクノロジーズ 生体分子分析装置
WO2020084705A1 (ja) * 2018-10-24 2020-04-30 株式会社日立ハイテク 生体ポリマ分析デバイス及びそれを用いた分析装置、並びに分析方法
GB201907244D0 (en) * 2019-05-22 2019-07-03 Oxford Nanopore Tech Ltd Method
IL291787A (en) 2019-09-29 2022-07-01 Qitan Tech Ltd Beijing mmup monomer variant and its application
IL293024B1 (en) * 2019-11-19 2026-07-01 Univ Groningen Artificial insemination, methods and uses
NL2024579B1 (en) * 2019-12-24 2021-09-06 Univ Delft Tech Protein and peptide fingerprinting and sequencing by nanopore translocation of peptide-oligonucleotide complexes
CN114807317A (zh) * 2021-01-22 2022-07-29 上海羿鸣生物科技有限公司 一种优化的dna线性扩增方法及试剂盒
GB202107192D0 (en) * 2021-05-19 2021-06-30 Oxford Nanopore Tech Ltd Method
CN113322180B (zh) * 2021-05-31 2022-07-15 中国科学院物理研究所 基于纳米孔测序的力谱分析方法和分析装置
WO2023049682A1 (en) 2021-09-22 2023-03-30 Illumina, Inc. Sequencing polynucleotides using nanopores
US20230298693A1 (en) * 2022-02-28 2023-09-21 Rajant Health Incorporated Alignment-free variant calling
CN120435657A (zh) 2022-10-28 2025-08-05 格罗宁根大学 蛋白质的基于纳米孔的分析
WO2024220969A2 (en) * 2023-04-21 2024-10-24 Arizona Board Of Regents On Behalf Of Arizona State University Novel transmembrane sensors and method of characterization for lysis-free detection of intracellular targets
WO2026073207A1 (en) 2024-09-30 2026-04-02 Illumina, Inc. Affinity-binder-based assay compositions and methods
CN119639558B (zh) * 2024-12-13 2025-09-26 杭州海兰时生物科技有限责任公司 一种用于单细胞测序的液滴融合系统
WO2026143014A1 (en) 2024-12-23 2026-07-02 Illumina, Inc. Affinity-binder-based assay compositions and methods for spatial proteomics

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5508179A (en) 1994-03-18 1996-04-16 Bio-Rad Laboratories, Inc. Use of deoxyribose nicotinamide adenine dinucleotide to enhance the specificity of NAD+ -dependent ligation reactions
US5795782A (en) * 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
EP1192103A1 (en) 1999-06-22 2002-04-03 President And Fellows of Harvard College Control of solid state dimensional features
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
JP2003521252A (ja) 2000-02-07 2003-07-15 イルミナ インコーポレイテッド ユニバーサルプライミングを用いる核酸検出方法
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
GB0505971D0 (en) 2005-03-23 2005-04-27 Isis Innovation Delivery of molecules to a lipid bilayer
EP2122344B8 (en) 2007-02-20 2019-08-21 Oxford Nanopore Technologies Limited Lipid bilayer sensor system
US20110229877A1 (en) * 2008-07-07 2011-09-22 Oxford Nanopore Technologies Limited Enzyme-pore constructs
DE202009019021U1 (de) 2008-09-22 2015-09-24 University Of Washington Msp-nanoporen
GB0905140D0 (en) * 2009-03-25 2009-05-06 Isis Innovation Method
EP2614156B1 (en) 2010-09-07 2018-08-01 The Regents of The University of California Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme
WO2013016486A1 (en) 2011-07-27 2013-01-31 The Board Of Trustees Of The University Of Illinois Nanopore sensors for biomolecular characterization
CN104039979B (zh) * 2011-10-21 2016-08-24 牛津纳米孔技术公司 使用孔和Hel308解旋酶表征目标多核苷酸的酶方法
CA2861808C (en) 2011-12-29 2021-02-23 Oxford Nanopore Technologies Limited Enzyme method
EP2798083B1 (en) 2011-12-29 2017-08-09 Oxford Nanopore Technologies Limited Method for characterising a polynucelotide by using a xpd helicase
JP5809572B2 (ja) 2012-01-30 2015-11-11 ルネサスエレクトロニクス株式会社 半導体装置
WO2013153359A1 (en) 2012-04-10 2013-10-17 Oxford Nanopore Technologies Limited Mutant lysenin pores
GB2559073A (en) * 2012-06-08 2018-07-25 Pacific Biosciences California Inc Modified base detection with nanopore sequencing
AU2013291763B2 (en) * 2012-07-19 2019-06-20 Oxford Nanopore Technologies Limited Modified helicases
ES2735015T3 (es) * 2013-11-26 2019-12-13 Illumina Inc Composiciones y métodos para secuenciar polinucleótidos

Also Published As

Publication number Publication date
JP2023116553A (ja) 2023-08-22
JP2021040646A (ja) 2021-03-18
EP3556869A1 (en) 2019-10-23
JP2017503473A (ja) 2017-02-02
JP2025072503A (ja) 2025-05-09
US11879155B2 (en) 2024-01-23
CA2926871C (en) 2022-08-16
WO2015081211A2 (en) 2015-06-04
AU2020202489A1 (en) 2020-05-07
ES2958715T3 (es) 2024-02-13
AU2022231786A1 (en) 2022-10-13
EP3074534A1 (en) 2016-10-05
US20210355534A1 (en) 2021-11-18
CA2926871A1 (en) 2015-06-04
AU2014354726A1 (en) 2016-06-02
US20150152495A1 (en) 2015-06-04
US20170268055A1 (en) 2017-09-21
CA3157586C (en) 2026-02-03
US20200024657A1 (en) 2020-01-23
US20240167085A1 (en) 2024-05-23
EP4282983A2 (en) 2023-11-29
EP3556869B1 (en) 2023-08-02
WO2015081178A1 (en) 2015-06-04
AU2022231786B2 (en) 2025-04-17
CA3157586A1 (en) 2015-06-04
ES2735015T3 (es) 2019-12-13
EP3074534B1 (en) 2019-05-01
CN113528632A (zh) 2021-10-22
US9689033B2 (en) 2017-06-27
JP6800749B2 (ja) 2020-12-23
US11041196B2 (en) 2021-06-22
AU2020202489B2 (en) 2022-06-23
CN105934522A (zh) 2016-09-07
EP4282983A3 (en) 2024-02-28
US10364462B2 (en) 2019-07-30
CN105934522B (zh) 2021-07-20
FI3556869T3 (fi) 2023-09-28
WO2015081211A3 (en) 2015-08-06
JP7349972B2 (ja) 2023-09-25
SI3074534T1 (sl) 2019-08-30
AU2014354726B2 (en) 2020-03-12
DK3074534T3 (da) 2019-07-29
LT3074534T (lt) 2019-08-26

Similar Documents

Publication Publication Date Title
IL282401A (en) Complement component irna compositions and methods of use thereof
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK2970456T3 (da) Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
DK2961831T3 (da) Sammensætninger og fremgangsmåder til immunterapi
DK3594348T3 (da) Kort c/ebp-alpha til aktivering af rna-sammensætninger og anvendelsesfremgangsmåder
DK3080274T3 (da) Fremgangsmåder og sammensætninger til genom-manipulation
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3071215T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3252160T3 (da) Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation
DK2978419T3 (da) Sammensætninger til forbedring af cellelevedygtighed og fremgangsmåder til anvendelse deraf
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK2972353T3 (da) Forbedrede fremgangsmåder til udførelse af multipleksanalyser
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
DK3071046T3 (da) Fremgangsmåde til ekstraktion af ærteproteiner
DK2929031T5 (da) Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf
DK3300610T3 (da) Fremgangsmåde til fraktionering af opløselige ærter
DK3484469T3 (da) Sammensætninger og fremgangsmåder til potentiering af antimikrober
DK2924093T3 (da) Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse
DK3394259T3 (da) Sammensætninger og fremgangsmåder til reducering af tau-ekspression
DK3065771T3 (da) Fremgangsmåder og sammensætninger til vedvarende immunterapi
DK3363805T3 (da) Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK2968269T3 (da) Fremgangsmåde til fremstilling af beta-3-agonister og mellemprodukter